Pedro J. Bermeo

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Viasat, Inc. of $600 million aggregate principal amount of its 5…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of $300 million aggregate principal amount of floating-rate notes due 2022, …

Davis Polk advised Banco Santander (México), S.A., Institución de Banca Múltiple, Grupo Financiero Santander México (“Banco Santander (México)”), a sociedad anónima organized under the laws…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Switzerland of CHF115 million aggregate principal amount of 0.441% fixed-rate notes due 2023. Banco…

Davis Polk advised the international placement agents in connection with the initial public offering of 240,000,000 common shares of Plaza S.A. by certain selling stockholders for an…

Davis Polk advised Auris Medical Holding AG on a public offering of common shares and warrants. The common shares are listed on the NASDAQ Global Market under the symbol “EARS.” Auris…

Davis Polk advised Goosehead Insurance, Inc. on its $98.095 million initial public offering of 9,809,500 shares of Class A common stock, which includes the full exercise of the underwriters…

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1.25 billion aggregate principal amount of 3.848% senior non-preferred fixed-rate notes due 2023,…

Davis Polk advised Affimed N.V. on its $26.5 million public offering of 13,225,000 of its common shares. Included in the shares are 1,725,000 shares sold by Affimed pursuant to the…

Davis Polk advised Auris Medical Holding AG on its registered direct offering of 12,499,999 of its common shares and concurrent private placement of warrants to purchase up to 7,499,999 of…